MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$11,890K
Net Income
-$18,230K
Net Profit Margin
-153.32%
EPS
-$0.15
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration and other research and development revenues
11,890
2,831
24,741
7,543
Research and development
20,180
17,600
27,404
19,775
General and administrative
11,603
10,234
11,353
12,316
Restructuring and impairment charges
-1,339
0
-6,261
0
Total operating expenses
30,444
27,834
32,496
32,091
Operating loss
-18,554
-25,003
-7,755
-24,548
Interest expense related to sale of future revenues
1,061
1,072
-464
2,399
Interest income, net
1,368
1,206
1,676
1,831
Other income (expense), net
17
-113
-5
-1
Total other income (expense), net
324
21
2,135
-569
Net loss
-18,230
-24,982
-5,620
-25,117
Basic EPS
-0.15
-0.26
-0.058
-0.28
Diluted EPS
-0.15
-0.26
-0.058
-0.28
Basic Average Shares
119,294,615
97,879,343
97,425,969
90,090,397
Diluted Average Shares
119,294,615
97,879,343
97,425,969
90,090,397
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income, net
$1,368K
(-34.45%↓ Y/Y)
Other income
(expense), net
$17K
(100.97%↑ Y/Y)
Net loss
-$18,230K
(65.76%↑ Y/Y)
Total other income
(expense), net
$324K
(119.16%↑ Y/Y)
Interest expense related
to sale of future...
$1,061K
(-47.48%↓ Y/Y)
Operating loss
-$18,554K
(64.00%↑ Y/Y)
Collaboration and other
research and development...
$11,890K
(232.31%↑ Y/Y)
Total operating
expenses
$30,444K
(-44.77%↓ Y/Y)
Restructuring and impairment
charges
-$1,339K
(-105.13%↓ Y/Y)
Research and development
$20,180K
(24.71%↑ Y/Y)
General and
administrative
$11,603K
(-9.77%↓ Y/Y)
Buy us a coffee
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT)